Cargando…

Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas

The recent discovery of activating mutations in the BRAF gene in many cutaneous melanomas led us to screen the genomic sequence of BRAF exons 11 and 15 in a series of 48 intraocular (uveal) melanomas, together with control samples from three cutaneous melanomas and the SK-Mel-28 cell line, which has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edmunds, S C, Cree, I A, Dí Nícolantonío, F, Hungerford, J L, Hurren, J S, Kelsell, D P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741050/ https://www.ncbi.nlm.nih.gov/pubmed/12778069 http://dx.doi.org/10.1038/sj.bjc.6600919

Ejemplares similares

Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma
por: Vetter, C S, et al.
Publicado: (2004)

Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development
por: Zuidervaart, W, et al.
Publicado: (2003)

Reduced Apaf-1 expression in human cutaneous melanomas
por: Dai, D L, et al.
Publicado: (2004)

Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival
por: Smith, S L, et al.
Publicado: (2002)

Mechanisms of local immunosuppression in cutaneous melanoma
por: Polak, M E, et al.
Publicado: (2007)

Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon
por: Gogas, H, et al.
Publicado: (2002)

Mitochondrial DNA damage in non-melanoma skin cancer
por: Durham, S E, et al.
Publicado: (2003)

Lymphatic density and metastatic spread in human malignant melanoma
por: Shields, J D, et al.
Publicado: (2004)

PTEN/MMAC1 expression in melanoma resection specimens
por: Deichmann, M, et al.
Publicado: (2002)

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
por: Zuidervaart, W, et al.
Publicado: (2005)

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker
por: Salazar-Onfray, F, et al.
Publicado: (2002)

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
por: Bernsen, M R, et al.
Publicado: (2003)

The T1799A point mutation is present in posterior uveal melanoma
por: Janssen, C S, et al.
Publicado: (2008)

Current State of Target Treatment in BRAF Mutated Melanoma
por: Tanda, Enrica Teresa, et al.
Publicado: (2020)

Cutaneous malignant melanoma in two rabbits (Oryctolagus cuniculus)
por: UEDA, Kengo, et al.
Publicado: (2018)

Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma
por: Senff-Ribeiro, A, et al.
Publicado: (2004)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

Prognostic Factors Five Years After Enucleation for Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2020)

Mutation landscape in melanoma patients clinical implications of heterogeneity of BRAF mutations
por: Heinzerling, L, et al.
Publicado: (2013)

Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer
por: Yu, J, et al.
Publicado: (2003)

Absence of human T-cell lymphotropic virus type I and human foamy virus in thymoma
por: Li, H, et al.
Publicado: (2004)

Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients
por: Osella-Abate, S, et al.
Publicado: (2003)

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
por: Vanni, Irene, et al.
Publicado: (2020)

Molecular Bases of Cutaneous and Uveal Melanomas
por: Gaudi, Sudeep, et al.
Publicado: (2011)

Focus on cutaneous and uveal melanoma specificities
por: Pandiani, Charlotte, et al.
Publicado: (2017)

Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling
por: Wang, Mona Meng, et al.
Publicado: (2021)

Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?
por: van den Bosch, Thomas, et al.
Publicado: (2010)

Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019
por: Masri, Rim, et al.
Publicado: (2022)

Polyclonality of BRAF mutations in primary melanoma and the selection of mutant alleles during progression
por: Lin, J, et al.
Publicado: (2011)

Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma
por: Glinkina, Kseniya, et al.
Publicado: (2022)

Spliceosome Mutations in Uveal Melanoma
por: Nguyen, Josephine Q.N., et al.
Publicado: (2020)

PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma
por: Vaquero-Garcia, Jorge, et al.
Publicado: (2017)

New Treatment Horizons in Uveal and Cutaneous Melanoma
por: Brănişteanu, Daciana Elena, et al.
Publicado: (2023)

Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level
por: Sakaizawa, K, et al.
Publicado: (2012)

ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells
por: Kaochar, Salma, et al.
Publicado: (2018)

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoprotein
por: Cui, R, et al.
Publicado: (2003)

Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus
por: Jackson, S, et al.
Publicado: (2002)

Tumour mutation status and sites of metastasis in patients with cutaneous melanoma
por: Adler, Nikki R, et al.
Publicado: (2017)

Episodic Src activation in uveal melanoma revealed by kinase activity profiling
por: Maat, W, et al.
Publicado: (2009)

Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients
por: Corrie, P G, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_jgh4vbj8o249ve07a74v203rb8